Early stage and long term treatment of multiple sclerosis with interferon-β

Abstract

Multiple sclerosis (MS) affects young adults during the most productive years of their lives, and until recently many neurologists were limited to treating symptoms and attacks without any ability to alter the disease course. The 1990s ushered in an era of possibility with the approval of three interferon-beta (IFNbeta) therapies for the treatment of MS… (More)

Topics

Cite this paper

@inproceedings{Applebee2009EarlySA, title={Early stage and long term treatment of multiple sclerosis with interferon-β}, author={Angela M Applebee and Hillel S. Panitch}, booktitle={Biologics : targets & therapy}, year={2009} }